Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9136 publications
The methyltransferase METTL3 promotes the progression of breast cancer cells via regulating EGF m6A modification.
Journal: Cell cycle (Georgetown, Tex.)
Published: October 09, 2025
Structural Diversity of Glycosylated Cytochalasins and Congeners from the Endophytic Fungus Trichoderma harzianum MLJ-4 with Anti-NSCLC Activity.
Journal: Journal of agricultural and food chemistry
Published: September 22, 2025
Design and synthesis of novel 3,5-diphenyl pyrazolines acting as potent EGFR inhibitors with off-target antileukemic effect.
Journal: Future medicinal chemistry
Published: September 15, 2025
Sunvozertinib (Zegfrovy) for NSCLC.
Journal: The Medical letter on drugs and therapeutics
Published: September 09, 2025
Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis.
Journal: BMJ (Clinical research ed.)
Published: September 02, 2025
Design and Synthesis of Marine-Inspired Itampolin A Derivatives to Overcome Chemoresistance in NSCLC via Cholesterol Homeostasis Modulation.
Journal: Marine drugs
Published: August 19, 2025
Design, synthesis, and antitumor activity study of novel oleanolic acid structural derivatives targeting c-Kit.
Journal: Bioorganic & medicinal chemistry letters
Published: August 16, 2025
Interpretable Transfer Learning for Cancer Drug Resistance: Candidate Target Identification.
Journal: Current issues in molecular biology
Published: July 26, 2025
Enhanced Tumor Treatment Outcomes of PEGylated Liposomal Gefitinib in Non-Small Cell Lung Cancer: A Comprehensive Preclinical Evaluation with Superior Therapeutic Efficacy.
Journal: AAPS PharmSciTech
Published: July 25, 2025
Correction to "Synthesis and Activity Study of Gefitinib Derivatives Inducing Mitochondrial Apoptosis in HeLa Cells".
Journal: Chemical biology & drug design
Published: July 23, 2025
Long-term survival with adaptive dual-targeted therapy in an epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer patient with mesenchymal-epithelial transition (MET) amplification guided by minimal residual disease (MRD) assessments: a case report and literature review.
Journal: Translational lung cancer research
Published: July 22, 2025
Last Updated: 10/31/2025